• Home
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • Services
    • Proteomics
    • Genomics Transcriptomics
    • Flow Cytometry
    • Assay Development
    • Monoclonal Antibodies
    • Biobanking
    • Biomarker Data Analyses
    • Biomarker Regulatory Services
  • Products
    • EASYCOV
    • FIMICS
    • BIOPRED
    • IVD Products
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
    • Your Customized Kit
  • R&D
  • Quality
  • Investors
    • Financial Management
    • Financial Data
    • Shareholders
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
  • Careers
Contact
Firalis
  • Home
  • About
  • Services
  • Products
  • R&D
  • Quality
  • Investors
  • Media
  • Proteomics

    Immunoassays to measure circulating and soluble markers

  • Genomics

    From Next-Generation Sequencing to qRT-PCR, complete solutions for genomic and transcriptomic discovery & profiling

  • Assay Development

    Custom assays meeting specific requirements

  • ALL SERVICES

    See our extensive range of biomarker discovery and validation services

  • EasyCOV Salivary Test for Covid-19

    Rapid and Easy Salivary Molecular Diagnostic Test of Covid-19

  • Biopred

    mRNA based targeted gene sequencing panel to better understand inflammatory-autoimmune disorders

  • Fimics

    Long non-coding RNA panel to better characterize patients with cardiac disorders and toxicities

  • Elisa Kits

    Colorimetric sandwich ELISA kits developed and validated for biomarker measurement in blood-derived matrices samples

a reliable partner at the heart of Europe

since its foundation in 2008, Firalis Group has been awarded for and contributed in

about a  hundred high-ranked research projects in biomarkers, playing a leading role towards the setting of

industry gold standards for the discovery, development and qualification of novel clinical biomarkers 

00274173126-firalis-flavicontop.png

Why Firalis

Firalis provides a comprehensive range of biomarker services from research to clinical qualification. Stratification at scientific and technical levels support biomarker discovery, validation, evaluation and qualification. Using our strong expertise and cutting-edge laboratory equipment, we develop and deliver customized solutions for biomarker assays according to your project needs.

3128195134129-firalis-flaviconmid.png
Who we are

Firalis is involved in several large scale projects for qualification of biomarkers in various clinical applications and led the efforts to improve industry standards, as the initiator of the SAFE-T consortium, largest ever biomarker research project co-funded by EU-IMI and Pharma.Today, Firalis validates and develops biomarker panels, following strictly
the EMA and FDA directions.

110283184132-firalis-flaviconbottom.png

What we do

Firalis' bioanalytical tools are developed

in a GMP compliant production facility certified with "ISO 13485", the international norm for medical device manufacture

and biomarker services are performed in laboratories certified with "ISO 17025",

the most important quality standard

for calibration and testing.

Recent news at Firalis

Le test Covid-19 qui fait saliver le monde !

Parution de Firalis dans le magazine régional Point Eco Alsace.

10.03.2021

Read More

EASYCOV: INAUGURATION DE LA LIGNE DE PRODUCTION

Firalis a inauguré la ligne de production automatisée, dédiée au production de "EasyCOV", le test rapide salivaire de dépistage du Covid-19 !

09.12.2020

Read More

HAS valide le remboursement d'EasyCOV*

*La Haute Autorité de Santé (HAS) valide l’utilisation et recommande le remboursement du test salivaire EasyCOV® sous conditions.

28.11.2020

Read More

TACKLING COVID-19: THE "COVIRNA" PROJECT

A diagnostic test funded by the EU, to improve surveillance and care of COVID-19 patients

27.11.2020

Read More

Load More

Follow us on

Contact Firalis

Firalis Group

© Copyright 2020 all rights reserved. 

The company logos, products and service marks are trademarks or registered trademarks of Firalis.

-----------------------------------------------------------------------------------------------------------------------

Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

-----------------------------------------------------------------------------------------------------------------------

Headquarter : 17 Rue du Fort 68330 Huningue FRANCE

follow Firalis on
Linkedin

EasyCOV

The first Covid-19 Rapid Salivary Test

99% Specific & 86% Sensitive

 

  • No more painful NP Swabs
  • No need for a Laboratory
  • Since 22/01/2021 officially equal to an RT-PCR Test!
  • Sample to Result time only 40 Minutes!
  • Result in an instant thanks to RT-LAMP Technology

 

LEARN MORE &

GET YOUR QUOTATION NOW !

EasyCOV

The first Covid-19 Rapid Salivary Test

99% Specific & 86% Sensitive

 

  • No more painful NP Swabs
  • No need for a Laboratory
  • Since 22/01/2021 officially equal to an RT-PCR Test!
  • Sample to Result time only 40 Minutes!
  • Result in an instant thanks to RT-LAMP Technology

 

LEARN MORE &

GET YOUR QUOTATION NOW !